“I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania
Public Health Genomics · 07.07.2026 · 29 (1) · 257-268
DOI: 10.1159/000551690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 07.07.2026. Verfasst von Daima Bukini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Patient Acceptance of Health Care. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Introduction
While curative treatments for sickle cell disease (SCD), including hematopoietic stem cell transplant and gene therapies, are largely restricted to high-resource settings, recent advancements have raised hopes that they will eventually become more accessible to patients in Africa, where the disease is particularly prominent and contributes to substantial morbidity and mortality. Understanding the factors that influence acceptability of curative therapies will therefore be important in developing strategies for successful adoption and implementation.
Methods
To address this need, a qualitative study was conducted to gain insights into the perspectives of patients and families in Tanzania regarding curative therapies for SCD, focusing on factors affecting treatment acceptability. A total of 81 individuals (46 caregivers and 35 patients) participated in focus group discussions or in-depth interviews; the majority were female (67%) and between 21 and 40 years of age.
Results
The results indicated substantial interest in current and prospective curative programs, with various factors influencing the attitudes of patients and caregivers differently. The findings suggested that caregivers’ decisions were likely to be influenced by the burden of caregiving roles and the financial costs related to care for SCD. Patients were more likely to accept the therapies if provided with information on safety of the therapies and transparency of data from treated patients.
Conclusion
In preparation for GT trials or transplants, tailored engagement strategies for patients younger than 18 years old will be necessary as the majority of SCD patients in Africa are children. Healthcare professionals must be well informed to address questions and concerns from patients’ families. Overall, the study highlighted strong interest in curative therapies for SCD in Tanzania while identifying important factors shaping acceptability, underscoring the need for tailored engagement and early involvement of affected families in program planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, dbukini1@jh.edu.
- Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- Novartis Biomedical Research, Cambridge, Massachusetts, USA.
Förderung
- Bill & Melinda Gates Foundation
Zitieren
APA
Bukini, D., Kassim, K., Kanza, C., Rifai, A., Chanzi, R., Amando, A., Amin, E., Spector, J., & Makani, J. (2026). “I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania. Public Health Genomics, 29(1), 257-268. https://doi.org/10.1159/000551690
Vancouver
Bukini D, Kassim K, Kanza C, Rifai A, Chanzi R, Amando A, et al. “I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania. Public Health Genomics. 2026;29(1):257-268. doi:10.1159/000551690
BibTeX
@article{Bukini2026,
author = {Bukini, Daima and Kassim, Kassim and Kanza, Collins and Rifai, Aisha and Chanzi, Rahma and Amando, Augostino and Amin, Elianna and Spector, Jonathan and Makani, Julie},
title = {“I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania},
journal = {Public Health Genomics},
year = {2026},
volume = {29},
number = {1},
pages = {257--268},
doi = {10.1159/000551690}
}
EUVIMED